On September 8, 2025, Beijing Youngen Biotechnology Co., Ltd. (Youngen) attended the 1st anniversary event of Bayer Co.Lab in China. This "Celebrate for Innovations" themed event aimed to jo...
Recently, a patent titled "siRNA for Inhibiting APP Gene Expression, Its Conjugates, and Applications" by Beijing Youngen Biotechnology Co., Ltd., Ltd. has been officially authorized. This p...
Recently, a patent for a small nucleic acid drug targeting heart failure developed by Beijing Youngen Biotechnology Co., Ltd has been officially granted. It is worth noting that currently, there are n...
On August 13,2024, a team of experts of the China National Intellectual Property Administration came to Youngen for training and guidance, and Youngen was awarded the title of 'Practice Base of t...
On October 20, 2023, Beijing Youngen Technology Co., Ltd., a subsidiary of Beijing Hotgen Biotechnology Co., Ltd., announced a strategic cooperation with Shanghai Genoval Biopharmaceutical T...
